Vanguard Global Advisers
WST icon

Vanguard Global Advisers’s West Pharmaceutical WST Stock Holding History

Vanguard Global Advisers’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.6M Sell
152,124
-5,613
-4% -$1.72M 0.03% 393
2026
Q1 		$39.5M Buy
+157,737
New +$39.2M 0.02% 457

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Global Advisers's WST Position: Q2 2026 in Review

Vanguard Global Advisers reduced its West Pharmaceutical (WST) stake by 3.6% in Q2 2026, selling an estimated $1.72M and leaving 152,124 shares worth $54.6M. The position accounts for 0.03% of the portfolio, ranked #393.

Vanguard Global Advisers first reported a position in WST in Q1 2026 and has held it in 2 quarters since. 785 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Vanguard Global Advisers held 152,124 shares of West Pharmaceutical worth $54.6M as of Q2 2026.
  • Vanguard Global Advisers sold 5,613 West Pharmaceutical shares in Q2 2026, an estimated $1.72M.
  • West Pharmaceutical made up 0.03% of Vanguard Global Advisers's portfolio in Q2 2026, its #393 holding.
  • Vanguard Global Advisers first reported a position in West Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
  • 785 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.